组胺
奥马佐单抗
免疫球蛋白E
免疫学
受体
补体系统
慢性荨麻疹
医学
抗体
药理学
内科学
标识
DOI:10.1016/j.imlet.2023.11.008
摘要
There is growing evidence suggesting that in a subset of patients with severe chronic urticaria [CSU] mast cells are activated via mechanisms that bypass the high affinity IgE receptor. This might explain why some patients do not respond at all to anti-IgE therapy [omalizumab]. The present article reviews the pathogenic mechanisms able to lead to histamine release from mast cells described so far in patients with CSU. These include the activation of the coagulation cascade, the activation of the complement system, the activation of the MRGPRX2 receptor, and the platelet activating factor vicious circle. The article suggests some possible interpretations for the clinical events occurring in this specific subset of patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI